Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
α-Synuclein in Parkinson's Disease: From Bench to Bedside.
Bellini G, D'Antongiovanni V, Palermo G, Antonioli L, Fornai M, Ceravolo R, Bernardini N, Derkinderen P, Pellegrini C. Bellini G, et al. Among authors: d antongiovanni v. Med Res Rev. 2024 Dec 20. doi: 10.1002/med.22091. Online ahead of print. Med Res Rev. 2024. PMID: 39704040 Review.
Correction: Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.
Di Salvo C, D'Antongiovanni V, Benvenuti L, d'Amati A, Ippolito C, Segnani C, Pierucci C, Bellini G, Annese T, Virgintino D, Colucci R, Antonioli L, Fornai M, Errede M, Bernardini N, Pellegrini C. Di Salvo C, et al. Among authors: d antongiovanni v. Food Funct. 2024 Dec 9;15(24):12257. doi: 10.1039/d4fo90116a. Food Funct. 2024. PMID: 39569862
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study.
Lucarini E, Benvenuti L, Di Salvo C, D'Antongiovanni V, Pellegrini C, Valdiserra G, Ciampi C, Antonioli L, Lambiase C, Cancelli L, Grosso A, Di Cesare Mannelli L, Bellini M, Ghelardini C, Fornai M. Lucarini E, et al. Among authors: d antongiovanni v. Front Pharmacol. 2024 Sep 20;15:1466824. doi: 10.3389/fphar.2024.1466824. eCollection 2024. Front Pharmacol. 2024. PMID: 39372212 Free PMC article.
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.
Di Salvo C, D'Antongiovanni V, Benvenuti L, d'Amati A, Ippolito C, Segnani C, Pierucci C, Bellini G, Annese T, Virgintino D, Colucci R, Antonioli L, Fornai M, Errede M, Bernardini N, Pellegrini C. Di Salvo C, et al. Among authors: d antongiovanni v. Food Funct. 2024 Oct 14;15(20):10323-10338. doi: 10.1039/d4fo02075h. Food Funct. 2024. PMID: 39302233
Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity.
D'Antongiovanni V, Fornai M, Colucci R, Nericcio A, Benvenuti L, Di Salvo C, Segnani C, Pierucci C, Ippolito C, Nemeth ZH, Haskó G, Bernardini N, Antonioli L, Pellegrini C. D'Antongiovanni V, et al. Acta Physiol (Oxf). 2025 Jan;241(1):e14232. doi: 10.1111/apha.14232. Epub 2024 Sep 17. Acta Physiol (Oxf). 2025. PMID: 39287080 Free PMC article.
Retraction Note: Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.
D'Antongiovanni V, Pellegrini C, Benvenuti L, Fornai M, Di Salvo C, Natale G, Ryskalin L, Bertani L, Lucarini E, Di Cesare Mannelli L, Ghelardini C, Nemeth ZH, Haskó G, Antonioli L. D'Antongiovanni V, et al. Inflammation. 2024 Sep 14. doi: 10.1007/s10753-024-02143-x. Online ahead of print. Inflammation. 2024. PMID: 39276301 No abstract available.
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot Study.
Bertani L, Antonioli L, Fornili M, D'Antongiovanni V, Ceccarelli L, Carmisciano L, Benvenuti L, Mumolo MG, Bottari A, Pardi V, Baiano Svizzero G, Baglietto L, De Bortoli N, Bellini M, Fornai M, Costa F. Bertani L, et al. Among authors: d antongiovanni v. Inflamm Bowel Dis. 2024 Dec 5;30(12):2449-2456. doi: 10.1093/ibd/izae133. Inflamm Bowel Dis. 2024. PMID: 38864707
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis.
Di Salvo C, D'Antongiovanni V, Benvenuti L, Fornai M, Valdiserra G, Natale G, Ryskalin L, Lucarini E, Mannelli LDC, Ghelardini C, Colucci R, Haskó G, Pellegrini C, Antonioli L. Di Salvo C, et al. Among authors: d antongiovanni v. J Drug Target. 2024 Sep;32(8):953-963. doi: 10.1080/1061186X.2024.2367563. Epub 2024 Jul 2. J Drug Target. 2024. PMID: 38864378
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury.
D'Antongiovanni V, Antonioli L, Benvenuti L, Pellegrini C, Di Salvo C, Calvigioni M, Panattoni A, Ryskalin L, Natale G, Banni S, Carta G, Ghelardi E, Fornai M. D'Antongiovanni V, et al. Br J Pharmacol. 2023 Dec;180(24):3215-3233. doi: 10.1111/bph.16200. Epub 2023 Aug 27. Br J Pharmacol. 2023. PMID: 37519261 Free article.
46 results